White Matter Damage in 4,725 Term-Born Infants Is Determined by Head Circumference at Birth: The Missing Link.

about

White Matter Damage in 4,725 Term-Born Infants Is Determined by Head Circumference at Birth: The Missing Link.

Item

http://www.wikidata.org/entity/Q52571386

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

White Matter Damage in 4,725 T ...... ce at Birth: The Missing Link.

@en

White Matter Damage in 4,725 T ...... ce at Birth: The Missing Link.

@nl

type

Item

label

White Matter Damage in 4,725 T ...... ce at Birth: The Missing Link.

@en

White Matter Damage in 4,725 T ...... ce at Birth: The Missing Link.

@nl

prefLabel

White Matter Damage in 4,725 T ...... ce at Birth: The Missing Link.

@en

White Matter Damage in 4,725 T ...... ce at Birth: The Missing Link.

@nl

P1476

White Matter Damage in 4,725 T ...... ce at Birth: The Missing Link.

@en

P2093

Bert Holmer

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology and causes of preterm birth

Autologous cord blood therapy for infantile cerebral palsy: from bench to bedside.

Clinical, ultrasound and molecular biomarkers for early prediction of large for gestational age infants in nulliparous women: An international prospective cohort study

Antecedents of cerebral palsy in very low-birth weight infants.

Birth size and brain function 75 years later.

Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy.

Case gender and severity in cerebral palsy varies with intrauterine growth

First Autologous Cord Blood Therapy for Pediatric Ischemic Stroke and Cerebral Palsy Caused by Cephalic Molding during Birth: Individual Treatment with Mononuclear Cells.

Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial

Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy.

P304

2120835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/2120835

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Arne Jensen

P577

2018-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29681945

http://www.w3.org/2001/XMLSchema#string

P921

human head circumference

P932

5851296

http://www.w3.org/2001/XMLSchema#string